Erschienen in:
07.03.2020 | Brief report
Diabetes and cardiovascular disease mortality among a population-based cohort of women with and without breast cancer
verfasst von:
Luis A. Rodriguez, Patrick T. Bradshaw, Humberto Parada, Nikhil K. Khankari, Tengteng Wang, Rebecca J. Cleveland, Susan L. Teitelbaum, Alfred I. Neugut, Marilie D. Gammon
Erschienen in:
Cancer Causes & Control
|
Ausgabe 5/2020
Einloggen, um Zugang zu erhalten
Abstract
Purpose
We investigated whether the relationship between diabetes and all-cause and CVD-related mortality differed between women with and without breast cancer among a cohort drawn from the same source population.
Methods
We interviewed 1,363 women newly diagnosed with breast cancer in 1996–1997, and 1,358 age-matched women without breast cancer, to assess history of physician-diagnosed diabetes. All-cause (n = 631) and CVD-specific mortality (n = 234) was determined by the National Death Index through 2009. We estimated multivariable-adjusted hazard ratios (HRs) for the rates of all-cause and CVD-specific mortality and, to account for competing causes of death, and subdistribution HRs (sHRs) for risk of CVD-related death.
Results
Among women with and without breast cancer, respectively, diabetes was associated with: all-cause mortality [HR (95% CI) 1.52 (1.13, 2.05) and 2.17 (1.46, 3.22)]; CVD-specific deaths [1.74 (1.06, 2.84) and 2.06 (1.11, 3.84)]; and risk of CVD-related death [sHR 1.36 (0.81, 2.27) and 1.79 (0.94, 3.40)]. Differences in effect estimates between women with and without breast cancer did not reach statistical significance (p-interaction > 0.10).
Conclusion
We found that the positive association between a history of physician-diagnosed diabetes and risk of all-cause and CVD-related mortality is of similar magnitude among a population-based cohort of women with or without breast cancer.